Open Labelled, Randomized Study to Evaluate the Efficacy, Safety and Dose Selection of VM-1500A-LAI Drug in HIV-infected Patients Transferred From Previous Stable Therapy (NNRTI + 2NRTI), Including ELPIDA®

Clinical trial NCT05163535 · COMPLETED

Trial details

NCT number: NCT05163535
Sponsor: Viriom
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

HIV-1-infection

Start date: 2021-01-19
Primary completion: 2021-08-03
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.